Studies Demonstrate High Adherence Levels, Acceptability Of Long-Acting, Injectable PrEP For HIV Prevention Among Varying Populations

Healio (2/28, Feller) reports, “Two studies presented at the Conference on Retroviruses and Opportunistic Infections demonstrated high adherence levels and acceptability of long-acting, injectable PrEP for HIV prevention among varying groups of people.” O...